Top Factor Driving Disseminated Intravascular Coagulation (DIC) Market Growth in 2025: Impact Of Rising Cancer Incidence On Coagulation Disorders

What market dynamics are playing a key role in accelerating the growth of the disseminated intravascular coagulation (dic) market?
The rising prevalence of cancer also drives the expansion of the disseminated intravascular coagulation (DIC) market. DIC, a condition characterized by excessive clotting and bleeding, is often triggered by cancer, as tumors can produce procoagulant substances that activate the coagulation cascade. With cancer cases projected to rise significantly-the National Cancer Institute forecasts 29.9 million new cases and 15.3 million cancer-related deaths annually by 2040-there will be a greater need for DIC treatments. The increasing incidence of cancer, therefore, plays a crucial role in driving the growth of the DIC market.

Get Your Disseminated Intravascular Coagulation (DIC) Market Report Here:
https://www.thebusinessresearchcompany.com/report/disseminated-intravascular-coagulation-dic-global-market-report

How will the growth rate of the disseminated intravascular coagulation (dic) market shape industry trends by 2034?
The disseminated intravascular coagulation (DIC) market has also grown strongly, increasing from $0.46 billion in 2024 to $0.49 billion in 2025 at a CAGR of 5.3%. The historical growth factors include the rise in sepsis cases, an increase in trauma-related incidents, a growing cancer incidence, higher healthcare spending, enhanced awareness among healthcare professionals, and a rise in adoption of targeted therapies.

The disseminated intravascular coagulation (DIC) market is poised for strong growth, reaching $0.59 billion by 2029 at a CAGR of 5.0%. Growth drivers include a rising focus on targeted therapies, early disease detection efforts, greater investments in healthcare infrastructure, expanded clinical research on coagulopathy treatments, and increasing awareness of rare hematological conditions. Major trends include improved diagnostic assays, the adoption of novel anticoagulant therapies, personalized medicine approaches, AI-driven diagnostics, enhanced patient monitoring technologies, and the development of targeted treatment solutions.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21172&type=smp

What trends are poised to drive the future success of the disseminated intravascular coagulation (dic) market?
In the disseminated intravascular coagulation (DIC) market, companies are advancing coagulation diagnostic technologies, such as next-generation blood clotting tests, to improve accuracy and speed in diagnosing DIC. For example, in June 2022, LumiraDx Limited, a UK-based healthcare company, expanded its cardiovascular testing portfolio, gaining CE Mark approvals for its NT-proBNP and updated D-Dimer tests. These tests enhance the LumiraDx Platform, supporting clinicians in diagnosing heart failure and ruling out venous thromboembolism, improving early detection and management of DIC and other thrombotic conditions.

Which primary segments of the disseminated intravascular coagulation (dic) market are driving growth and industry transformations?
The disseminated intravascular coagulation (DIC) market covered in this report is segmented -

1) By Treatment: Medicines, Transfusions, Surgery, Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam, Partial Thromboplastin Time (PTT), Fibrinogen Blood Test, D-dimer, Other Diagnoses
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Medicines: Anticoagulants, Antiplatelet Drugs, Fibrinolytics, Procoagulants, Antithrombin Therapy
2) By Transfusions: Platelet Transfusion, Fresh Frozen Plasma (FFP), Cryoprecipitate Transfusion, Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus, Organ Surgery
4) By Other Treatments: Plasma Exchange, Supportive Care, Steroid Therapy

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21172

Which geographical regions are pioneering growth in the disseminated intravascular coagulation (dic) market?
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in the disseminated intravascular coagulation (DIC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the disseminated intravascular coagulation (dic) market landscape?
Major companies operating in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21172&type=smp

What Is Covered In The Disseminated Intravascular Coagulation (DIC) Global Market Report?

•Market Size Forecast: Examine the disseminated intravascular coagulation (dic) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the disseminated intravascular coagulation (dic) market for a structured understanding.
•Key Players Overview: Analyze major players in the disseminated intravascular coagulation (dic) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the disseminated intravascular coagulation (dic) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the disseminated intravascular coagulation (dic) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the disseminated intravascular coagulation (dic) market.
•Industry Challenges: Identify potential risks and obstacles affecting the disseminated intravascular coagulation (dic) market.
•Competitive Landscape: Review strategic developments in the disseminated intravascular coagulation (dic) market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.